Identifying Key Clinical Indicators Associated with the Risk of Death in Hospitalized COVID-19 Patients

被引:0
作者
Ma, Qinglan [1 ]
Ren, Jingxin [1 ]
Chen, Lei [2 ]
Guo, Wei [3 ,4 ]
Feng, Kaiyan [5 ]
Huang, Tao [6 ,7 ]
Cai, Yu-Dong [1 ]
机构
[1] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China
[2] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China
[3] Shanghai Jiao Tong Univ Sch Med SJTUSM, Key Lab Stem Cell Biol, Shanghai 200030, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Biol Sci SIBS, Shanghai 200030, Peoples R China
[5] Guangdong AIB Polytech Coll, Dept Comp Sci, Guangzhou 510507, Peoples R China
[6] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Biomed Big Data Ctr,CAS Key Lab Computat Biol, Shanghai 200031, Peoples R China
[7] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai 200031, Peoples R China
基金
国家重点研发计划;
关键词
COVID-19; mortality risk; clinical indicator; machine learning; classification; feature selection; MORTALITY; DISEASE; PREDICTOR; DEMENTIA; IMPACT;
D O I
10.2174/0115748936306893240720192301
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background Accurately predicting survival in hospitalized COVID-19 patients is crucial but challenging due to multiple risk factors. This study addresses the limitations of existing research by proposing a comprehensive machine-learning framework to identify key mortality risk factors and develop a robust predictive model.Objective This study proposes an analytical framework that leverages various machine learning techniques to predict the survival of hospitalized COVID-19 patients accurately. The framework comprehensively evaluates multiple clinical indicators and their associations with mortality risk.Method Patient data, including gender, age, health condition, and smoking habits, was divided into discharged (n=507) and deceased (n=300) categories. Each patient was characterized by 92 clinical features. The framework incorporated seven feature ranking algorithms (LASSO, LightGBM, MCFS, mRMR, RF, CATBoost, and XGBoost), the IFS method, and four classification algorithms (DT, KNN, RF, and SVM).Results Age, diabetes, dyspnea, chronic kidney failure, and high blood pressure were identified as the most important risk factors. The best model achieved an F1-score of 0.857 using KNN with 34 selected features.Conclusion Our findings provide a comprehensive analysis of COVID-19 mortality risk factors and develops a robust predictive model. The findings highlight the increased risk in patients with comorbidities, consistent with existing literature. The proposed framework can aid in developing personalized treatment plans and allocating healthcare resources effectively.
引用
收藏
页数:19
相关论文
共 118 条
  • [1] The impact of atrial fibrillation on outcomes in patients hospitalized with COVID-19
    Agarwal, Siddharth
    Munir, Muhammad Bilal
    Stavrakis, Stavros
    Piccini, Jonathan P.
    Asad, Zain Ul Abideen
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 111 : 127 - 129
  • [2] The impact of age on intensive care
    Akinosoglou, Karolina
    Schinas, Georgios
    Almyroudi, Maria Panagiota
    Gogos, Charalambos
    Dimopoulos, George
    [J]. AGEING RESEARCH REVIEWS, 2023, 84
  • [3] Does COVID-19 Cause Hypertension?
    Akpek, Mahmut
    [J]. ANGIOLOGY, 2022, 73 (07) : 682 - 687
  • [4] Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients
    Alizadehsani, Roohallah
    Sani, Zahra Alizadeh
    Behjati, Mohaddeseh
    Roshanzamir, Zahra
    Hussain, Sadiq
    Abedini, Niloofar
    Hasanzadeh, Fereshteh
    Khosravi, Abbas
    Shoeibi, Afshin
    Roshanzamir, Mohamad
    Moradnejad, Pardis
    Nahavandi, Saeid
    Khozeimeh, Fahime
    Zare, Assef
    Panahiazar, Maryam
    Acharya, U. Rajendra
    Islam, Sheikh Mohammed Shariful
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (04) : 2307 - 2320
  • [5] Dyspnea: The vanished warning symptom of COVID-19 pneumonia
    Allali, Gilles
    Marti, Christophe
    Grosgurin, Olivier
    Morelot-Panzini, Capucine
    Similowski, Thomas
    Adler, Dan
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) : 2272 - 2273
  • [6] Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis
    Alqahtani, Jaber S.
    Oyelade, Tope
    Aldhahir, Abdulelah M.
    Alghamdi, Saeed M.
    Almehmadi, Mater
    Alqahtani, Abdullah S.
    Quaderi, Shumonta
    Mandal, Swapna
    Hurst, John R.
    [J]. PLOS ONE, 2020, 15 (05):
  • [7] Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19
    Angeli, Fabio
    Marazzato, Jacopo
    Verdecchia, Paolo
    Balestrino, Antonella
    Bruschi, Claudio
    Ceriana, Piero
    Chiovato, Luca
    Dalla Vecchia, Laura Adelaide
    De Ponti, Roberto
    Fanfulla, Francesco
    La Rovere, Maria Teresa
    Perego, Francesca
    Scalvini, Simonetta
    Spanevello, Antonio
    Traversi, Egidio
    Visca, Dina
    Vitacca, Michele
    Bachetti, Tiziana
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 89 : 81 - 86
  • [8] Severe covid-19 pneumonia: pathogenesis and clinical management
    Attaway, Amy H.
    Scheraga, Rachel G.
    Bhimraj, Adarsh
    Biehl, Michelle
    Hatipoglu, Umur
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
  • [9] Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?
    Aydemir, Selim
    Aksakal, Emrah
    Aydinyilmaz, Faruk
    Gulcu, Oktay
    Sarac, Ibrahim
    Aydin, Sidar Siyar
    Dogan, Remziye
    Lazoglu, Merve
    Kalkan, Kamuran
    [J]. EGYPTIAN HEART JOURNAL, 2022, 74 (01)
  • [10] The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality
    Bannay, Aurelie
    Chaignot, Christophe
    Blotiere, Pierre-Olivier
    Basson, Mickael
    Weill, Alain
    Ricordeau, Philippe
    Alla, Francois
    [J]. MEDICAL CARE, 2016, 54 (02) : 188 - 194